Hans Hartung : oficina do gesto.

Por Hartung, Hans
Publicado em 2014

Hartung /

Por Hartung, Hans, Descargues, Pierre
Publicado em 1977

Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis

Por Chun, Jerold, Hartung, Hans-Peter
Publicado em 2010

Atacicept: targeting B cells in multiple sclerosis

Por Hartung, Hans-Peter, Kieseier, Bernd C.
Publicado em 2010

Interferon Gamma and Sonic Hedgehog Signaling Are Required to Dysregulate Murine Neural Stem/Precursor Cells

Por Walter, Janine, Hartung, Hans-Peter, Dihné, Marcel
Publicado em 2012

Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis

Por Ingwersen, Jens, Aktas, Orhan, Hartung, Hans-Peter
Publicado no Neurotherapeutics (2015)

Alemtuzumab: A new therapy for active relapsing–remitting multiple sclerosis

Por Hartung, Hans-Peter, Aktas, Orhan, Boyko, Alexey N
Publicado no Mult Scler (2015)

Redox Events As Modulators of Pathology and Therapy of Neuroinflammatory Diseases

Por Lepka, Klaudia, Berndt, Carsten, Hartung, Hans-Peter, Aktas, Orhan
Publicado no Front Cell Dev Biol (2016)

Cloning and Expression of the dnaK Gene of Campylobacter jejuni and Antigenicity of Heat Shock Protein 70

Por Thies, Frank L., Karch, Helge, Hartung, Hans-Peter, Giegerich, Gerhard
Publicado em 1999

Niche-dependent development of functional neuronal networks from embryonic stem cell-derived neural populations

Por Illes, Sebastian, Theiss, Stephan, Hartung, Hans-Peter, Siebler, Mario, Dihné, Marcel
Publicado em 2009

Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies

Por Leussink, Verena I., Hartung, Hans-Peter, Kieseier, Bernd C., Stettner, Mark
Publicado no Ther Adv Neurol Disord (2016)

Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine

Por Warnke, Clemens, Wiendl, Heinz, Hartung, Hans-Peter, Stüve, Olaf, Kieseier, Bernd C
Publicado em 2010

Age-Dependent Modulation of Cortical Transcriptomes in Spinal Cord Injury and Repair

Por Jaerve, Anne, Kruse, Fabian, Malik, Katharina, Hartung, Hans-Peter, Müller, Hans Werner
Publicado em 2012

CD8(+) Phagocyte Recruitment in Rat Experimental Autoimmune Encephalomyelitis: Association with Inflammatory Tissue Destruction

Por Schroeter, Michael, Stoll, Guido, Weissert, Robert, Hartung, Hans-Peter, Lassmann, Hans, Jander, Sebastian
Publicado em 2003

Pathogenesis and Treatment of Immune-Mediated Neuropathies

Por Lehmann, Helmar C., zu Horste, Gerd Meyer, Kieseier, Bernd C., Hartung, Hans-Peter
Publicado em 2009

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis

Por Warnke, Clemens, Stüve, Olaf, Hartung, Hans-Peter, Fogdell-Hahn, Anna, Kieseier, Bernd C
Publicado em 2011

Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis

Por Havla, Joachim, Warnke, Clemens, Derfuss, Tobias, Kappos, Ludwig, Hartung, Hans-Peter, Hohlfeld, Reinhard
Publicado no Dtsch Arztebl Int (2016)

Antigen therapy eliminates T cell inflammation by apoptosis: Effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2

Por Weishaupt, Andreas, Gold, Ralf, Gaupp, Stefanie, Giegerich, Gerhard, Hartung, Hans-Peter, Toyka, Klaus V.
Publicado em 1997

Review of teriflunomide and its potential in the treatment of multiple sclerosis

Por Warnke, Clemens, Meyer zu Hörste, Gerd, Hartung, Hans-Peter, Stüve, Olaf, Kieseier, Bernd C
Publicado em 2009

Risk evaluation and monitoring in multiple sclerosis therapeutics

Por Clanet, Michel C, Wolinsky, Jerry S, Ashton, Raymond J, Hartung, Hans-Peter, Reingold, Stephen C
Publicado no Mult Scler (2014)